Avadel Pharmaceuticals to Present at the Jefferies Healthcare Conference

Rhea-AI Summary

Avadel Pharmaceuticals plc (Nasdaq: AVDL) announced that CEO Greg Divis and CFO Tom McHugh will participate in a fireside chat at the Jefferies Healthcare Conference on June 9 at 4:00 p.m. E.T.

The event will be available via live webcast and archived for 90 days on Avadel’s Investor Relations website. The company focuses on transforming medicines, with its lead drug candidate FT218, a once-nightly formulation for treating excessive daytime sleepiness and cataplexy in adults with narcolepsy.

DUBLIN, Ireland, June 02, 2022 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that Greg Divis, Chief Executive Officer, and Tom McHugh, Chief Financial Officer, will participate in a fireside chat at the Jefferies Healthcare Conference on Thursday, June 9, at 4:00 p.m. E.T.

A live webcast of the fireside chat, as well as an archived recording, will be available on Avadel’s Investor Relations website, investors.avadel.com, for 90 days following the conference.

About Avadel Pharmaceuticals plc

Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Our current lead drug candidate, FT218, is an investigational formulation of sodium oxybate leveraging our proprietary drug delivery technology and designed to be taken once at bedtime for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. For more information, please visit www.avadel.com.

Investor Contact:
Courtney Turiano
Stern Investor Relations, Inc.
Courtney.Turiano@sternir.com
(212) 698-8687

Media Contact:
Nicole Raisch Goelz
Real Chemistry
ngoelz@realchemistry.com
(408) 568-4292

FAQ

When is the Avadel Pharmaceuticals fireside chat at the Jefferies Healthcare Conference?

The fireside chat will take place on June 9 at 4:00 p.m. E.T.

Who will represent Avadel Pharmaceuticals at the Jefferies Healthcare Conference?

Greg Divis, CEO, and Tom McHugh, CFO, will represent Avadel Pharmaceuticals.

Where can I watch the Avadel Pharmaceuticals fireside chat?

The event will be available via live webcast on Avadel’s Investor Relations website.

What is Avadel Pharmaceuticals' lead drug candidate?

Avadel's lead drug candidate is FT218, designed to treat excessive daytime sleepiness and cataplexy in adults with narcolepsy.

How long will the webcast of the Avadel Pharmaceuticals event be available?

The archived recording will be available for 90 days following the conference.